Skip to main
DOX

Amdocs (DOX) Stock Forecast & Price Target

Amdocs (DOX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Amdocs is a total return story, where the company is focused on generating roughly a 10% return for investors through a combination of EPS growth and the dividend yield. The company's strong Q2 results, including better-than-expected revenue, gross margin, EBIT, EBIT margin, EPS, and FCF, demonstrate its ability to drive growth in its core markets of digital business systems and legacy systems. The company's focus on digital transformation, AI, and cloud adoption is also a positive indicator of its long-term potential and positioning in a rapidly evolving industry. While there are potential risks, such as customer concentration and integration following M&A, Amdocs's consistently strong financials and growth outlook make it a solid investment opportunity.

Bears say

Amdocs is facing challenges in Europe with slowing growth and a lack of significant customer wins, while also dealing with a relatively unchanged operating environment. Additionally, the company will need to replace a significant portion of its revenue in FY27 as managed services contracts end. The recent acquisition of Matrixx may not generate expected revenue, and the departure of the current CEO may create uncertainty within the company's leadership.

Amdocs (DOX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Amdocs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Amdocs (DOX) Forecast

Analysts have given Amdocs (DOX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Amdocs (DOX) has a Strong Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Amdocs (DOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.